Simultaneously increased expression of microRNA-155 and suppressor of cytokine signaling 1 (SOCS1) gene in the peripheral blood mononuclear cells of patients with primary Sjögren's syndrome

International Journal of Rheumatic Diseases

Volumn 20, Issue 5, 2017, Pages 609-613

  Chen, Ji Qing ^a   Zilahi, Erika ^a   Papp, Gábor ^a   Sipka, Sándor ^a   Zeher, Margit ^a  

^a UNIVERSITY OF DEBRECEN   (Hungary)

Author keywords

microRNA 155 (miR 155); primary Sj gren's syndrome (pSS); suppressor of cytokine signaling 1 (SOCS1)

Indexed keywords

MICRORNA 155; SUPPRESSOR OF CYTOKINE SIGNALING 1; MICRORNA; MIRN155 MICRORNA, HUMAN; SOCS1 PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENE FUNCTION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOPATHOGENESIS; INFLAMMATION; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIMARY SJOEGREN SYNDROME; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SJOEGREN SYNDROME; SOCS1 GENE; VERY ELDERLY; BLOOD; CASE CONTROL STUDY; GENETIC MARKER; GENETICS; METABOLISM; MIDDLE AGED; MONONUCLEAR CELL; UPREGULATION;

AGED; CASE-CONTROL STUDIES; FEMALE; GENETIC MARKERS; HUMANS; LEUKOCYTES, MONONUCLEAR; MALE; MICRORNAS; MIDDLE AGED; REAL-TIME POLYMERASE CHAIN REACTION; SJOGREN'S SYNDROME; SUPPRESSOR OF CYTOKINE SIGNALING 1 PROTEIN; UP-REGULATION;

EID: 84960157597     PISSN: 17561841     EISSN: 1756185X     Source Type: Journal    
DOI: 10.1111/1756-185X.12804     Document Type: Article

References (26)

1. Ramos-Casals M, Tzioufas AG, Font J (2005) Primary Sjögren's syndrome: new clinical and therapeutic concepts. Ann Rheum Dis 64, 347–54.
2. Zeher M (2009). Sjögren's syndrome. In: Zeher M, Szodoray P (eds) Sjögren's syndrome and associated disorders, pp 1–25. Transworld Research Network, Kerala.
3. Jimenez SA, Piera-Velazquez S (2013) Potential role of human-specific genes, human-specific microRNAs and human-specific non-coding regulatory RNAs in the pathogenesis of systemic sclerosis and Sjögren's syndrome. Autoimmun Rev 12, 1046–51.
4. Bartel DP (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116, 281–97.
5. Chua JH, Armugam A, Jeyaseelan K (2009) MicroRNAs: biogenesis, function and applications. Curr Opin Mol Ther 11, 189–99.
6. Wang H, Peng W, Ouyang X, Li W, Dai Y (2012) Circulating microRNAs as candidate biomarkers in patients with systemic lupus erythematosus. Transl Res J Lab Clin Med 160, 198–206.
7. Furer V, Greenberg JD, Attur M, Abramson SB, Pillinger MH (2010) The role of microRNA in rheumatoid arthritis and other autoimmune diseases. Clin Immunol 136, 1–15.
8. Kapsogeorgou EK, Gourzi VC, Manoussakis MN, Moutsopoulos HM, Tzioufas AG (2011) Cellular microRNAs (miRNAs) and Sjögren's syndrome: candidate regulators of autoimmune response and autoantigen expression. J Autoimmun 37, 129–35.
9. Pauley KM, Stewart CM, Gauna AE et al. (2011) Altered miR-146a expression in Sjögren's syndrome and its functional role in innate immunity. Eur J Immunol 41, 2029–39.
10. Zilahi E, Tarr T, Papp G, Griger Z, Sipka S, Zeher M (2012) Increased microRNA-146a/b, TRAF6 gene and decreased IRAK1 gene expressions in the peripheral mononuclear cells of patients with Sjögren's syndrome. Immunol Lett 141, 165–8.
11. Leng RX, Pan HF, Qin WZ, Chen GM, Ye DQ (2011) Role of microRNA-155 in autoimmunity. Cytokine Growth Factor Rev 22, 141–7.
12. Kanwal N, John P, Bhatti A (2013) MicroRNA-155 as a therapeutic target for inflammatory diseases. Rheumatol Int 33, 557–60.
13. Lind EF, Ohashi PS (2014) Mir-155, a central modulator of T cell responses. Eur J Immunol 44, 11–5.
14. Vitali C, Bombardieri S, Jonsson R et al. (2002) Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 61, 554–8.
15. Yoshimura A, Naka T, Kubo M (2007) SOCS proteins, cytokine signalling and immune regulation. Nat Rev Immunol 7, 454–65.
16. Lu LF, Thai TH, Calado DP et al. (2009) Foxp3-dependent microRNA-155 confers competitive fitness to regulatory T cells by targeting SOCS1 protein. Immunity 30, 80–91.
17. Wang P, Hou J, Lin L et al. (2010) Inducible microRNA-155 feedback promotes type I IFN signaling in antiviral innate immunity by targeting suppressor of cytokine signaling 1. J Immunol Baltim 185, 6226–33.
18. Li X, Tian F, Wang F (2013) Rheumatoid arthritis associated microRNA-155 targets SOCS1 and upregulates TNFα and IL-1β in PBMCs. Int J Mol Sci 14, 23910–21.
19. Shi H, Zheng L, Zhang P, Yu C (2014) miR-146a and miR-155 expression in PBMCs from patients with Sjögren's syndrome. J Oral Pathol Med 43, 792–7.
20. Hatton OL, Harris-Arnold A, Schaffert S, Krams SM, Martinez OM (2014) The interplay between Epstein-Barr virus and B lymphocytes: implications for infection, immunity, and disease. Immunol Res 58, 268–76.
21. Lucchesi D, Pitzalis C, Bombardieri M (2014) EBV and other viruses as triggers of tertiary lymphoid structures in primary Sjögren's syndrome. Expert Rev Clin Immunol 10, 445–55.
22. Croia C, Astorri E, Murray-Brown W et al. (2014) Implication of Epstein-Barr virus infection in disease-specific autoreactive B cell activation in ectopic lymphoid structures of Sjögren's syndrome. Arthritis Rheumatol 66, 2545–57.
23. Jiang S, Zhang HW, Lu MH et al. (2010) MicroRNA-155 functions as an OncomiR in breast cancer by targeting the suppressor of cytokine signaling 1 gene. Cancer Res 70, 3119–27.
24. Zhu X, Wang Y, Sun Y, Zhu D (2013) MiR-155 up-regulation by LMP1 DNA contributes to increased nasophayngeal carcinoma cell proliferation and migration. Eur Arch Otorhinolarongol 271, 1939–45.
25. Graham JP, Arcipowski KM, Bishop GA (2010) Differential B-lymphocyte regulation by CD40 and its viral mimic, latent membrane protein 1. Immunol Rev 237, 226–48.
26. Michaud F, Coulombe F, Gaudeault E, Paquet-Bouchard C, Rola-Pleszczynski M, Gosselin J (2010) Epstein-Barr virus interferes with the amplification of IFN alpha secretion by activating suppressor of cytokine signaling 3 in primary monocytes of cytokine signaling. PLoS ONE 5, e11908.